COMBI — Combigene AB Income Statement
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro CapSucker Stock
- SEK133.66m
- SEK13.15m
- SEK26.70m
Annual income statement for Combigene AB, fiscal year end - December 31st, SEK millions except per share, conversion factor applied.
2018 December 31st | 2019 December 31st | R2020 December 31st | 2021 December 31st | 2022 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | Interim Report | ARS | ARS |
| Standards: | SAS | SAS | — | SAS | SAS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 0.008 | 0 | 0 | 84 | 26.7 |
| Selling / General / Administrative Expenses | |||||
| Depreciation and Amortization | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 13.2 | 17.7 | 28.2 | 63.1 | 33.6 |
| Operating Profit | -13.2 | -17.7 | -28.2 | 21 | -6.95 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -13.1 | -17.9 | -29.6 | 21 | -6.16 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -13.1 | -17.9 | -29.6 | 21 | -6.16 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Net Income | -13.1 | -17.6 | -29.4 | 21 | -6.16 |
| Adjustments to Net Income | |||||
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -13.1 | -17.6 | -29.4 | 21 | -6.16 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -9.47 | -5.54 | -3.18 | 1.34 | -0.195 |
| Dividends per Share |